Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-13-020691
Filing Date
2013-03-14
Accepted
2013-03-14 17:15:23
Documents
1
Period of Report
2013-03-12

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 5670
  Complete submission text file 0001104659-13-020691.txt   7034
Mailing Address C/O ALNYLAM PHARMACEUTICALS, INC 300 THIRD STREET CAMBRIDGE MA 02142
Business Address
Westphal Christoph H (Reporting) CIK: 0001291961 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35403 | Film No.: 13691283

Mailing Address 215 FIRST STREET SUITE 440 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 440 CAMBRIDGE MA 02142 617-252-9300
Verastem, Inc. (Issuer) CIK: 0001526119 (see all company filings)

EIN.: 273269467 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations